Paul C. Lorigan

Paul C. Lorigan

Alderley Park
Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 233 publications

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 12, 2026

primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.

primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 16, 2026

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

Journal: Journal for immunotherapy of cancer

Published: March 31, 2026

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Journal: Diabetes care

Published: March 23, 2026

HosTIL territory: mapping the landscape of toxicity in TIL therapy.

HosTIL territory: mapping the landscape of toxicity in TIL therapy.

Journal: Journal for immunotherapy of cancer

Published: March 20, 2026

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2026

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2026

Hepatitis at Home: Ambulatory management of severe immune checkpoint inhibitor related hepatitis.

Hepatitis at Home: Ambulatory management of severe immune checkpoint inhibitor related hepatitis.

Journal: QJM : monthly journal of the Association of Physicians

Published: March 19, 2026

Patterns of systemic treatment for melanoma: An insight on trends and costs between 2019-2023 from the English systemic anti-cancer therapy national database.

Patterns of systemic treatment for melanoma: An insight on trends and costs between 2019-2023 from the English systemic anti-cancer therapy national database.

Journal: EJC skin cancer

Published: January 19, 2026

Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations.

Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations.

Journal: EJC skin cancer

Published: January 19, 2026

Translating ctDNA into cutaneous melanoma care: An international expert survey.

Translating ctDNA into cutaneous melanoma care: An international expert survey.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 13, 2026

Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma.

Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma.

Journal: Cancer discovery

Published: December 18, 2025

Showing 1-12 of 233

Last Updated: 09/26/2026